Tenor Capital Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Tenor Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Tenor Capital Management from 13F filings

Historical chart of Tenor Capital Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Tenor Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Tenor Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $15M 11M 1.41

More positions owned by Tenor Capital Management

Seagate Hdd Cayman Note 3.500% 6/0 (Principal)
Interdigital Note 3.500% 6/0 (Principal)
Ringcentral Note 3/1 (Principal)
Dexcom Note 0.250%11/1 (Principal)
Teladoc Health Note 1.250% 6/0 (Principal)
Akamai Technologies Note 0.375% 9/0 (Principal)
Unity Software Note 11/1 (Principal)
Cloudflare Note 8/1 (Principal)
Bentley Sys Note 0.125% 1/1 (Principal)
Jamf Hldg Corp Note 0.125% 9/0 (Principal)
Conmed Corp Note 2.250% 6/1 (Principal)
Haemonetics Corp Mass Note 3/0 (Principal)
Novocure Note 11/0 (Principal)
Tripadvisor Note 0.250% 4/0 (Principal)
Jbt Marel Corporation Note 0.250% 5/1 (Principal)

View all positions for Tenor Capital Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
LMR Partners
Camden Asset Management
Balyasny Asset Management
DLD Asset Management
Point72 Asset Management
Davidson Kempner Capital Management
Jpmorgan Chase & Co
Jain Global
Nuveen
Lazard Asset Management
State Street Corporation
Absolute Investment Advisers
Citadel Advisors
Linden Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1